Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

18.2%

2 terminated out of 11 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

36%

4 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

80% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (5)
P 2 (1)
P 3 (3)
P 4 (1)

Trial Status

Completed8
Terminated2
Active Not Recruiting1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (11)

Research Network

Activity Timeline